140 related articles for article (PubMed ID: 38351735)
1. Successful treatment pure red cell aplasia after ABO major mismatched allogeneic hematopoietic stem cell transplantation with avatrombopag and low dose rituximab.
Cao J; Lu S; Luo D; Pei R; Lu Y; Chen D; Du X; Li S
Transfusion; 2024 Mar; 64(3):510-516. PubMed ID: 38351735
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.
Helbig G; Stella-Holowiecka B; Krawczyk-Kulis M; Wojnar J; Markiewicz M; Wojciechowska-Sadus M; Kopera M; Kruzel T; Najda J; Nowak K; Holowiecki J
Haematologica; 2005 Nov; 90 Suppl():ECR33. PubMed ID: 16266924
[TBL] [Abstract][Full Text] [Related]
3. Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation.
Jung SH; Ahn JS; Yang DH; Chul Park H; Bae SY; Kim YK; Kim HJ; Lee JJ
Case Rep Oncol; 2012 Jan; 5(1):110-3. PubMed ID: 22539923
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
Zhu KE; Li JP; Zhang T; Zhong J; Chen J
Hematology; 2007 Apr; 12(2):117-21. PubMed ID: 17454192
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Pure Red Cell Aplasia Following Major ABO-Incompatible Hematopoietic Stem Cell Transplantation.
Zhu P; Wu Y; Cui D; Shi J; Yu J; Zhao Y; Lai X; Liu L; Xie J; Huang H; Luo Y
Front Immunol; 2022; 13():829670. PubMed ID: 35222414
[TBL] [Abstract][Full Text] [Related]
6. [Pure red cell aplasia following ABO-incompatible allogeneic hematopoietic stem cell transplantation].
Fan H; Jing Y; Li HH; Lu XC; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):364-7. PubMed ID: 18426666
[TBL] [Abstract][Full Text] [Related]
7. [Pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation].
Huang XJ; Liu DH; Xu LP; Han W; Jiang Q; Chen YH; Zhang YC; Liu KY; Bao L; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):548-50. PubMed ID: 16468333
[TBL] [Abstract][Full Text] [Related]
8. Treatment for pure red cell aplasia after major ABO-incompatible allogeneic stem cell transplantation: a multicentre study.
Longval T; Galimard JE; Leprêtre AC; Suarez F; Amiranoff D; Cazaux M; Kaphan E; Michonneau D; Dhedin N; Coman T; Nguyen Quoc S; Peffault de Latour R; Resche-Rigon M; Sicre de Fontbrune F
Br J Haematol; 2021 May; 193(4):814-826. PubMed ID: 33844842
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of pure red cell aplasia using therapeutic plasma exchange after ABO-incompatible hematopoietic stem cell transplant.
Vivero A; Peedin AR; Gao Y; Karp JK
J Clin Apher; 2023 Aug; 38(4):495-499. PubMed ID: 36703597
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of pure red cell aplasia because of ABO major mismatched stem cell transplant.
Sackett K; Cohn CS; Fahey-Ahrndt K; Smith AR; Johnson AD
J Clin Apher; 2018 Feb; 33(1):108-112. PubMed ID: 28543448
[TBL] [Abstract][Full Text] [Related]
11. Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies.
Helbig G; Stella-Holowiecka B; Wojnar J; Krawczyk M; Krzemien S; Wojciechowska-Sadus M; Markiewicz M; Wylezol I; Kopera M; Holowiecki J
Ann Hematol; 2007 Sep; 86(9):677-83. PubMed ID: 17486341
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells for the treatment of refractory pure red cell aplasia after major ABO-incompatible hematopoietic stem cell transplantation.
Fang B; Song Y; Li N; Li J; Han Q; Zhao RC
Ann Hematol; 2009 Mar; 88(3):261-6. PubMed ID: 18769919
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of refractory pure red cell aplasia with eltrombopag after ABO-incompatible allogeneic hematopoietic stem cell transplantation.
Gao Y; Gao F; Shi J; Fu H; Huang H; Zhao Y
J Zhejiang Univ Sci B; 2021 Aug; 22(8):695-700. PubMed ID: 34414703
[TBL] [Abstract][Full Text] [Related]
14. Eltrombopag for the Treatment of Refractory Pure RBC Aplasia after Major ABO Incompatible Hematopoietic Stem Cell Transplantation.
Busca A; Dellacasa C; Giaccone L; Manetta S; Biale L; Godio L; Aydin S; Festuccia M; Brunello L; Bruno B
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1765-1770. PubMed ID: 29684566
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of refractory red cell aplasia after allogeneic hematopoietic cell transplantation with daratumumab.
Salas MQ; Alahmari A; Lipton JH
Eur J Haematol; 2020 Feb; 104(2):145-147. PubMed ID: 31693245
[TBL] [Abstract][Full Text] [Related]
16. Pure Red Cell Aplasia following ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation: Resolution with Daratumumab Treatment.
Henig I; Yehudai-Ofir D; Zohar Y; Zuckerman T
Acta Haematol; 2021; 144(6):683-687. PubMed ID: 33887733
[TBL] [Abstract][Full Text] [Related]
17. Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question.
Marco-Ayala J; Gómez-Seguí I; Sanz G; Solves P
Bone Marrow Transplant; 2021 Apr; 56(4):769-778. PubMed ID: 33188257
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia.
Maschan AA; Skorobogatova EV; Balashov DN; Pashanov ED; Trakhtman PE; Schipitzina IP; Skvortsova YV; Rumiantzev AG
Bone Marrow Transplant; 2002 Sep; 30(6):405-7. PubMed ID: 12235527
[TBL] [Abstract][Full Text] [Related]
19. Antigen-Specific Immunoadsorption With the Glycosorb® ABO Immunoadsorption System as a Novel Treatment Modality in Pure Red Cell Aplasia Following Major and Bidirectional ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation.
Handisurya A; Worel N; Rabitsch W; Bojic M; Pajenda S; Reindl-Schwaighofer R; Winnicki W; Vychytil A; Knaus HA; Oberbauer R; Derfler K; Wohlfarth P
Front Med (Lausanne); 2020; 7():585628. PubMed ID: 33195341
[TBL] [Abstract][Full Text] [Related]
20. Rituximab added to conditioning regimen significantly improves erythroid engraftment in major incompatible ABO-group hematopoietic stem cell transplantation.
Finazzi MC; Weber A; Pavoni C; Grassi A; Micò MC; Algarotti A; Lussana F; Rambaldi A
Bone Marrow Transplant; 2024 Jun; 59(6):751-758. PubMed ID: 38402345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
